A novel investigation of the combined efficacy of venetoclax plus R-CHOP in patients with DLBCL overexpressing both MYC and BCL2 proteins could not detect prolonged PFS in comparison to R-CHOP alone, but instead resulted in higher toxicity [238]. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.